Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder

Bibliography

• Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007;64(5):543-52
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2013;15(1):1-44
   PubMed Web of Science ®Google Scholar
• Quiroz JA, Gray NA, Kato T, Manji HK. Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 2008;33(11):2551-65
   PubMed Web of Science ®Google Scholar
• Clay Montier LL, Deng JJ, Bai Y. Number matters: control of mammalian mitochondrial DNA copy number. J Genet Genomics 2009;36(3):125-31
   PubMed Web of Science ®Google Scholar
• Malik AN, Czajka A. Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction? Mitochondrion 2013;13(5):481-92
   PubMed Web of Science ®Google Scholar
• MacAskill AF, Kittler JT. Control of mitochondrial transport and localization in neurons. Trends Cell Biol 2010;20(2):102-12
   PubMedGoogle Scholar
• Cai Q, Gerwin C, Sheng ZH. Syntabulin-mediated anterograde transport of mitochondria along neuronal processes. J Cell Biol 2005;170(6):959-69
   PubMed Web of Science ®Google Scholar
• Smith MJ, Pozo K, Brickley K, Stephenson FA. Mapping the GRIF-1 binding domain of the kinesin, KIF5C, substantiates a role for GRIF-1 as an adaptor protein in the anterograde trafficking of cargoes. J Biol Chem 2006;281(37):27216-28
   PubMed Web of Science ®Google Scholar
• Taya S, Shinoda T, Tsuboi D, et al. DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J Neurosci 2007;27(1):15-26
   PubMedGoogle Scholar
• MacAskill AF, Atkin TA, Kittler JT. Mitochondrial trafficking and the provision of energy and calcium buffering at excitatory synapses. Eur J Neurosci 2010;32(2):231-40
   PubMed Web of Science ®Google Scholar
• Song Z, Ghochani M, McCaffery JM, et al. Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol Biol Cell 2009;20(15):3525-32
   PubMed Web of Science ®Google Scholar
• Palmer CS, Osellame LD, Stojanovski D, Ryan MT. The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Cell Signal 2011;23(10):1534-45
   PubMed Web of Science ®Google Scholar
• Massaad CA, Klann E. Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid Redox Signal 2011;14(10):2013-54
   PubMed Web of Science ®Google Scholar
• Du J, Wang Y, Hunter R, et al. Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci USA 2009;106(9):3543-8
   PubMed Web of Science ®Google Scholar
• Liu W, Zhou C. Corticosterone reduces brain mitochondrial function and expression of mitofusin, BDNF in depression-like rodents regardless of exercise preconditioning. Psychoneuroendocrinology 2012;37(7):1057-70
   PubMedGoogle Scholar
• Chen G, Creson T, Engel S, et al. Neurotrophic actions of mood-stabilizers: a recent research discovery and its potential clinical applications. Curr Psychiatry Rev 2005;1:173-85
   Google Scholar
• Yang F, He XP, Russell J, Lu B. Ca2+ influx-independent synaptic potentiation mediated by mitochondrial Na(+)-Ca2+ exchanger and protein kinase C. J Cell Biol 2003;163(3):511-23
   PubMedGoogle Scholar
• Rizzuto R, Pozzan T. Microdomains of intracellular Ca2+: molecular determinants and functional consequences. Physiol Rev 2006;86(1):369-408
   PubMed Web of Science ®Google Scholar
• Baron KT, Wang GJ, Padua RA, et al. NMDA-evoked consumption and recovery of mitochondrially targeted aequorin suggests increased Ca2+ uptake by a subset of mitochondria in hippocampal neurons. Brain Res 2003;993(1-2):124-32
   PubMedGoogle Scholar
• Machado-Vieira R, Manji HK, Zarate CA. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 2009;11(Suppl 2):92-109
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med 2009;361(16):1570-83
   PubMed Web of Science ®Google Scholar
• Ma DK, Marchetto MC, Guo JU, et al. Epigenetic choreographers of neurogenesis in the adult mammalian brain. Nat Neurosci 2010;13(11):1338-44
   PubMed Web of Science ®Google Scholar
• Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci 2010;11(5):339-50
   PubMed Web of Science ®Google Scholar
• Culmsee C, Mattson MP. p53 in neuronal apoptosis. Biochem Biophys Res Commun 2005;331(3):761-77
   PubMed Web of Science ®Google Scholar
• Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008;9(1):47-59
   PubMed Web of Science ®Google Scholar
• Shoshan-Barmatz V, Ben-Hail D. VDAC, a multi-functional mitochondrial protein as a pharmacological target. Mitochondrion 2012;12(1):24-34
   PubMed Web of Science ®Google Scholar
• Hunsberger J, Austin DR, Henter ID, Chen G. The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues Clin Neurosci 2009;11(3):333-48
   PubMedGoogle Scholar
• Son H, Yu IT, Hwang SJ, et al. Lithium enhances long-term potentiation independently of hippocampal neurogenesis in the rat dentate gyrus. J Neurochem 2003;85(4):872-81
   PubMedGoogle Scholar
• Hu D, Serrano F, Oury TD, Klann E. Aging-dependent alterations in synaptic plasticity and memory in mice that overexpress extracellular superoxide dismutase. J Neurosci 2006;26(15):3933-41
   PubMed Web of Science ®Google Scholar
• Thiels E, Urban NN, Gonzalez-Burgos GR, et al. Impairment of long-term potentiation and associative memory in mice that overexpress extracellular superoxide dismutase. J Neurosci 2000;20(20):7631-9
   PubMed Web of Science ®Google Scholar
• Li Z, Jo J, Jia JM, et al. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 2010;141(5):859-71
   PubMed Web of Science ®Google Scholar
• Jiao S, Li Z. Nonapoptotic function of BAD and BAX in long-term depression of synaptic transmission. Neuron 2011;70(4):758-72
   PubMedGoogle Scholar
• Jonas E. BCL-xL regulates synaptic plasticity. Mol Interv 2006;6(4):208-22
   PubMedGoogle Scholar
• Creson TK, Yuan P, Manji HK, Chen G. Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate. J Mol Neurosci 2009;37(2):123-34
   PubMedGoogle Scholar
• Mattson MP, Gleichmann M, Cheng A. Mitochondria in neuroplasticity and neurological disorders. Neuron 2008;60(5):748-66
   PubMed Web of Science ®Google Scholar
• Palmer CS, Osellame LD, Stojanovski D, Ryan MT. The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Cell Signal 2011;23(10):1534-45
   PubMed Web of Science ®Google Scholar
• Sheng ZH, Cai Q. Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci 2012;13(2):77-93
   PubMed Web of Science ®Google Scholar
• Corena-McLeod M, Walss-Bass C, Oliveros A, et al. New model of action for mood stabilizers: phosphoproteome from rat pre-frontal cortex synaptoneurosomal preparations. PLoS One 2013;8(5):e52147
   Google Scholar
• Jou MJ. Pathophysiological and pharmacological implications of mitochondria-targeted reactive oxygen species generation in astrocytes. Adv Drug Deliv Rev 60(13-14):1512-26
   PubMedGoogle Scholar
• Cheng A, Hou Y, Mattson MP. Mitochondria and neuroplasticity. ASN Neuro 2010;2(5):e00045
   PubMed Web of Science ®Google Scholar
• McMahon FJ, Stine OC, Meyers DA, et al. Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet 1995;56(6):1277-86
   PubMedGoogle Scholar
• Kirk R, Furlong RA, Amos W, et al. Mitochondrial genetic analyses suggest selection against maternal lineages in bipolar affective disorder. Am J Hum Genet 1999;65(2):508-18
   PubMedGoogle Scholar
• Munakata K, Tanaka M, Mori K, et al. Mitochondrial DNA 3644T– >C mutation associated with bipolar disorder. Genomics 2004;84(6):1041-50
   PubMedGoogle Scholar
• Kong QP, Bandelt HJ, Sun C, et al. Updating the East Asian mtDNA phylogeny: a prerequisite for the identification of pathogenic mutations. Hum Mol Genet 2006;15(13):2076-86
   PubMed Web of Science ®Google Scholar
• Rollins B, Martin MV, Sequeira PA, et al. Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One 2009;4(3):e4913
   Google Scholar
• Kato T, Kunugi H, Nanko S, Kato N. Mitochondrial DNA polymorphisms in bipolar disorder. J Affect Disord 2001;62(3):151-64
   PubMedGoogle Scholar
• Washizuka S, Iwamoto K, Kazuno AA, et al. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder in Japanese and the National Institute of Mental Health pedigrees. Biol Psychiatry 2004;56(7):483-9
   PubMedGoogle Scholar
• Atkin TA, MacAskill AF, Brandon NJ, Kittler JT. Disrupted in Schizophrenia-1 regulates intracellular trafficking of mitochondria in neurons. Mol Psychiatry 2011;16(2):122-4; 21
   PubMed Web of Science ®Google Scholar
• Blackwood DH, Fordyce A, Walker MT, et al. Schizophrenia and affective disorders – cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001;69(2):428-33
   PubMedGoogle Scholar
• Consortium WTCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447(7145):661-78
   PubMed Web of Science ®Google Scholar
• Hodgkinson CA, Goldman D, Jaeger J, et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 2004;75(5):862-72
   PubMedGoogle Scholar
• Thomson PA, Wray NR, Millar JK, et al. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol Psychiatry 2005;10(7):657-68; 16
   PubMedGoogle Scholar
• Hennah W, Thomson P, McQuillin A, et al. DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol Psychiatry 2009;14(9):865-73
   PubMed Web of Science ®Google Scholar
• Schosser A, Gaysina D, Cohen-Woods S, et al. Association of DISC1 and TSNAX genes and affective disorders in the depression case-control (DeCC) and bipolar affective case-control (BACCS) studies. Mol Psychiatry 2010;15(8):844-9
   PubMedGoogle Scholar
• Xiao Y, Zhang J, Wang Y, et al. Limited association between Disrupted in Schizophrenia 1 (DISC1) gene and bipolar disorder in the Chinese population. Psychiatr Genet 2011;21(1):42-6
   PubMedGoogle Scholar
• Detera-Wadleigh SD, McMahon FJ. G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 2006;60(2):106-14
   PubMedGoogle Scholar
• Kvajo M, Dhilla A, Swor DE, et al. Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Mol Psychiatry 2008;13(7):685-96
   PubMed Web of Science ®Google Scholar
• Chen H, Chan DC. Emerging functions of mammalian mitochondrial fusion and fission. Hum Mol Genet 2005;14(Spec No. 2):R283-9
   PubMedGoogle Scholar
• Ferreira MA, O’Donovan MC, Meng YA, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008;40(9):1056-8
   PubMed Web of Science ®Google Scholar
• Group PGCBDW. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011;43(10):977-83
   PubMed Web of Science ®Google Scholar
• Kato T, Stine OC, McMahon FJ, Crowe RR. Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder. Biol Psychiatry 1997;42(10):871-5
   PubMedGoogle Scholar
• Sequeira A, Martin MV, Rollins B, et al. Mitochondrial mutations and polymorphisms in psychiatric disorders. Front Genet 2012;3:103
   PubMedGoogle Scholar
• Shao L, Martin MV, Watson SJ, et al. Mitochondrial involvement in psychiatric disorders. Ann Med 2008;40(4):281-95
   PubMed Web of Science ®Google Scholar
• Kakiuchi C, Ishiwata M, Kametani M, et al. Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia. Int J Neuropsychopharmacol 2005;8(4):515-22
   PubMed Web of Science ®Google Scholar
• Sabunciyan S, Kirches E, Krause G, et al. Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder. J Neural Transm 2007;114(5):665-74
   PubMedGoogle Scholar
• Fuke S, Kametani M, Kato T. Quantitative analysis of the 4977-bp common deletion of mitochondrial DNA in postmortem frontal cortex from patients with bipolar disorder and schizophrenia. Neurosci Lett 2008;439(2):173-7
   PubMed Web of Science ®Google Scholar
• Stine OC, Luu SU, Zito M, Casanova M. The possible association between affective disorder and partially deleted mitochondrial DNA. Biol Psychiatry 1993;33(2):141-2
   PubMedGoogle Scholar
• Chang CC, Jou SH, Lin TT, Liu CS. Mitochondria DNA variation and increased oxidative damage in euthymic patients with bipolar disorder. Psychiatry Clin Neurosci 2014; [ Epub ahead of print]
   Google Scholar
• de Sousa RT, Uno M, Zanetti MV, et al. Leukocyte mitochondrial DNA copy number in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2014;48:32-5
   PubMed Web of Science ®Google Scholar
• Vawter MP, Tomita H, Meng F, et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry 2006;11(7):615; 63-79
   PubMed Web of Science ®Google Scholar
• Torrell H, Montaña E, Abasolo N, et al. Mitochondrial DNA (mtDNA) in brain samples from patients with major psychiatric disorders: gene expression profiles, mtDNA content and presence of the mtDNA common deletion. Am J Med Genet B Neuropsychiatr Genet 2013;162B(2):213-23
   PubMedGoogle Scholar
• Grintzalis K, Zisimopoulos D, Grune T, et al. Method for the simultaneous determination of free/protein malondialdehyde and lipid/protein hydroperoxides. Free Radic Biol Med 2013;59:27-35
   PubMed Web of Science ®Google Scholar
• Mahadik SP, Evans D, Lal H. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2001;25(3):463-93
   PubMed Web of Science ®Google Scholar
• Soeiro-de-Souza MG, Andreazza AC, Carvalho AF, et al. Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder. Int J Neuropsychopharmacol 2013;16(7):1505-12
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Frey BN, Erdtmann B, et al. DNA damage in bipolar disorder. Psychiatry Res 2007;153(1):27-32
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Dal-Pizzol F, Teixeira AL, et al. Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res 2011;45(2):156-61
   PubMed Web of Science ®Google Scholar
• Banerjee U, Dasgupta A, Rout JK, Singh OP. Effects of lithium therapy on Na+-K+-ATPase activity and lipid peroxidation in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2012;37(1):56-61
   PubMed Web of Science ®Google Scholar
• Kunz M, Gama CS, Andreazza AC, et al. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008;32(7):1677-81
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Kauer-Sant’anna M, Frey BN, et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 2008;111(2-3):135-44
   PubMed Web of Science ®Google Scholar
• Gubert C, Stertz L, Pfaffenseller B, et al. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. J Psychiatr Res 2013;47(10):1396-402
   PubMed Web of Science ®Google Scholar
• Magalhães PV, Jansen K, Pinheiro RT, et al. Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. Int J Neuropsychopharmacol 2012;15(8):1043-50
   PubMedGoogle Scholar
• de Sousa RT, Zarate CA, Zanetti MV, et al. Oxidative stress in early stage Bipolar Disorder and the association with response to lithium. J Psychiatr Res 2014;50:36-41
   PubMed Web of Science ®Google Scholar
• Berk M, Berk L, Dodd S, et al. Stage managing bipolar disorder. Bipolar Disord 2013; [Epub ahead of print]
   Google Scholar
• Reddy R, Sahebarao MP, Mukherjee S, Murthy JN. Enzymes of the antioxidant defense system in chronic schizophrenic patients. Biol Psychiatry 1991;30(4):409-12
   PubMed Web of Science ®Google Scholar
• Fontoura PC, Pinto VL, Matsuura C, et al. Defective nitric oxide-cyclic guanosine monophosphate signaling in patients with bipolar disorder: a potential role for platelet dysfunction. Psychosom Med 2012;74(8):873-7
   PubMedGoogle Scholar
• Andreazza AC, Cassini C, Rosa AR, et al. Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 2007;41(6):523-9
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Andreazza AC, Viale CI, et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 2007;421(1):33-6
   PubMed Web of Science ®Google Scholar
• Kuloglu M, Ustundag B, Atmaca M, et al. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 2002;20(2):171-5
   PubMed Web of Science ®Google Scholar
• Abdalla DS, Monteiro HP, Oliveira JA, Bechara EJ. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients. Clin Chem 1986;32(5):805-7
   PubMedGoogle Scholar
• Savas HA, Gergerlioglu HS, Armutcu F, et al. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry 2006;7(1):51-5
   PubMed Web of Science ®Google Scholar
• Raffa M, Barhoumi S, Atig F, et al. Reduced antioxidant defense systems in schizophrenia and bipolar I disorder. Prog Neuropsychopharmacol Biol Psychiatry 2012;39(2):371-5
   PubMed Web of Science ®Google Scholar
• Ranjekar PK, Hinge A, Hegde MV, et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 2003;121(2):109-22
   PubMed Web of Science ®Google Scholar
• Ozcan ME, Gulec M, Ozerol E, et al. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 2004;19(2):89-95
   PubMed Web of Science ®Google Scholar
• Gergerlioglu HS, Savas HA, Bulbul F, et al. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Prog Neuropsychopharmacol Biol Psychiatry 2007;31(3):697-702
   PubMed Web of Science ®Google Scholar
• Selek S, Savas HA, Gergerlioglu HS, et al. The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord 2008;107(1-3):89-94
   PubMed Web of Science ®Google Scholar
• Khairova R, Pawar R, Salvadore G, et al. Effects of lithium on oxidative stress parameters in healthy subjects. Mol Med Rep 2012;5(3):680-2
   PubMed Web of Science ®Google Scholar
• Liochev SI, Fridovich I. The relative importance of HO* and ONOO- in mediating the toxicity of O*-. Free Radic Biol Med 1999;26(5-6):777-8
   PubMedGoogle Scholar
• Berman SB, Hastings TG. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson’s disease. J Neurochem 1999;73(3):1127-37
   PubMed Web of Science ®Google Scholar
• Lai CT, Yu PH. Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem Pharmacol 1997;53(3):363-72
   PubMedGoogle Scholar
• Andreazza AC, Kapczinski F, Kauer-Sant’Anna M, et al. 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci 2009;34(4):263-71
   PubMed Web of Science ®Google Scholar
• Berk M, Copolov DL, Dean O, et al. N-acetyl cysteine for depressive symptoms in bipolar disorder – a double-blind randomized placebo-controlled trial. Biol Psychiatry 2008;64(6):468-75
   PubMed Web of Science ®Google Scholar
• Montero D, Walther G, Perez-Martin A, et al. Endothelial dysfunction, inflammation, and oxidative stress in obese children and adolescents: markers and effect of lifestyle intervention. Obes Rev 2012;13(5):441-55
   PubMed Web of Science ®Google Scholar
• Andrades M, Ritter C, Moreira JC, Dal-Pizzol F. Oxidative parameters differences during non-lethal and lethal sepsis development. J Surg Res 2005;125(1):68-72
   PubMedGoogle Scholar
• Halliwell B, Gutteridge JM. Free radicals in biology and medicine. 4th edition. Oxford University Press, Inc; New York, USA: 2007
   Google Scholar
• Sun X, Wang JF, Tseng M, Young LT. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci 2006;31(3):189-96
   PubMed Web of Science ®Google Scholar
• Konradi C, Eaton M, MacDonald ML, et al. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 2004;61(3):300-8
   PubMed Web of Science ®Google Scholar
• Iwamoto K, Bundo M, Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 2005;14(2):241-53
   PubMed Web of Science ®Google Scholar
• Naydenov AV, MacDonald ML, Ongur D, Konradi C. Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Arch Gen Psychiatry 2007;64(5):555-64
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Shao L, Wang JF, Young LT. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 2010;67(4):360-8
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Wang JF, Salmasi F, et al. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem 2013;127(4):552-61
   PubMed Web of Science ®Google Scholar
• Maurer IC, Schippel P, Volz HP. Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue. Bipolar Disord 2009;11(5):515-22
   PubMed Web of Science ®Google Scholar
• MacDonald ML, Naydenov A, Chu M, et al. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord 2006;8(3):255-64
   PubMedGoogle Scholar
• Kim HW, Rapoport SI, Rao JS. Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis 2010;37(3):596-603
   PubMed Web of Science ®Google Scholar
• Cataldo AM, McPhie DL, Lange NT, et al. Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol 2010;177(2):575-85
   PubMed Web of Science ®Google Scholar
• Kato T, Takahashi S, Shioiri T, et al. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 1994;31(2):125-33
   PubMed Web of Science ®Google Scholar
• Kato T, Shioiri T, Murashita J, et al. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol Med 1995;25(3):557-66
   PubMed Web of Science ®Google Scholar
• Hamakawa H, Kato T, Shioiri T, et al. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychol Med 1999;29(3):639-44
   PubMedGoogle Scholar
• Hamakawa H, Murashita J, Yamada N, et al. Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin Neurosci 2004;58(1):82-8
   PubMed Web of Science ®Google Scholar
• Weber WA, Dudley J, Lee JH, et al. A pilot study of alterations in high energy phosphoryl compounds and intracellular pH in unmedicated adolescents with bipolar disorder. J Affect Disord 2013;150(3):1109-13
   PubMed Web of Science ®Google Scholar
• Kato T, Takahashi S, Shioiri T, Inubushi T. Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 1992;26(4):223-30
   PubMed Web of Science ®Google Scholar
• Kato T, Takahashi S, Shioiri T, Inubushi T. Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J Affect Disord 1993;27(1):53-9
   PubMed Web of Science ®Google Scholar
• Jensen JE, Daniels M, Haws C, et al. Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients. Exp Clin Psychopharmacol 2008;16(3):199-206
   PubMedGoogle Scholar
• Kim DJ, Lyoo IK, Yoon SJ, et al. Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry 2007;31(6):1182-8
   PubMedGoogle Scholar
• Chu WJ, Delbello MP, Jarvis KB, et al. Magnetic resonance spectroscopy imaging of lactate in patients with bipolar disorder. Psychiatry Res 2013;213(3):230-4
   PubMedGoogle Scholar
• Dager SR, Friedman SD, Parow A, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004;61(5):450-8
   PubMed Web of Science ®Google Scholar
• Regenold WT, Phatak P, Marano CM, et al. Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biol Psychiatry 2009;65(6):489-94
   PubMed Web of Science ®Google Scholar
• Madhavarao CN, Chinopoulos C, Chandrasekaran K, Namboodiri MA. Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain. J Neurochem 2003;86(4):824-35
   PubMedGoogle Scholar
• Sager TN, Topp S, Torup L, et al. Evaluation of CA1 damage using single-voxel 1H-MRS and un-biased stereology: can non-invasive measures of N-acetyl-asparate following global ischemia be used as a reliable measure of neuronal damage? Brain Res 2001;892(1):166-75
   PubMed Web of Science ®Google Scholar
• Winsberg ME, Sachs N, Tate DL, et al. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000;47(6):475-81
   PubMed Web of Science ®Google Scholar
• Cecil KM, DelBello MP, Morey R, Strakowski SM. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 2002;4(6):357-65
   PubMedGoogle Scholar
• Bertolino A, Frye M, Callicott JH, et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 2003;53(10):906-13
   PubMed Web of Science ®Google Scholar
• Chang K, Adleman N, Dienes K, et al. Decreased N-acetylaspartate in children with familial bipolar disorder. Biol Psychiatry 2003;53(11):1059-65
   PubMedGoogle Scholar
• Deicken RF, Fein G, Weiner MW. Abnormal frontal lobe phosphorous metabolism in bipolar disorder. Am J Psychiatry 1995;152(6):915-18
   PubMedGoogle Scholar
• Sassi RB, Stanley JA, Axelson D, et al. Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. Am J Psychiatry 2005;162(11):2109-15
   PubMedGoogle Scholar
• Atmaca M, Yildirim H, Ozdemir H, et al. Hippocampal 1H MRS in first-episode bipolar I patients. Prog Neuropsychopharmacol Biol Psychiatry 2006;30(7):1235-9
   PubMedGoogle Scholar
• Kalaycı D, Ozdel O, Sözeri-Varma G, et al. A proton magnetic resonance spectroscopy study in schizoaffective disorder: comparison of bipolar disorder and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2012;37(1):176-81
   PubMed Web of Science ®Google Scholar
• Kraguljac NV, Reid M, White D, et al. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry Res 2012;203(2-3):111-25
   PubMed Web of Science ®Google Scholar
• Singh MK, Jo B, Adleman NE, et al. Prospective neurochemical characterization of child offspring of parents with bipolar disorder. Psychiatry Res 2013;214(2):153-60
   PubMedGoogle Scholar
• Howells FM, Ives-Deliperi VL, Horn NR, Stein DJ. Increased thalamic phospholipid concentration evident in bipolar I disorder. Prog Neuropsychopharmacol Biol Psychiatry 2013;41:1-5
   PubMed Web of Science ®Google Scholar
• Gigante AD, Lafer B, Yatham LN. (1)H-MRS of hippocampus in patients after first manic episode. World J Biol Psychiatry 2014;15(2):145-54
   PubMed Web of Science ®Google Scholar
• Deicken RF, Pegues MP, Anzalone S, et al. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am J Psychiatry 2003;160(5):873-82
   PubMedGoogle Scholar
• Hajek T, Bauer M, Pfennig A, et al. Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study. J Psychiatry Neurosci 2012;37(3):185-92
   PubMedGoogle Scholar
• Silverstone PH, Wu RH, O’Donnell T, et al. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol 2003;18(2):73-9
   PubMedGoogle Scholar
• Brambilla P, Stanley JA, Nicoletti MA, et al. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord 2005;86(1):61-7
   PubMedGoogle Scholar
• Gallelli KA, Wagner CM, Karchemskiy A, et al. N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder. Bipolar Disord 2005;7(6):589-97
   PubMed Web of Science ®Google Scholar
• Friedman SD, Dager SR, Parow A, et al. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol Psychiatry 2004;56(5):340-8
   PubMedGoogle Scholar
• Adler CM, DelBello MP, Weber WA, et al. Neurochemical effects of quetiapine in patients with bipolar mania: a proton magnetic resonance spectroscopy study. J Clin Psychopharmacol 2013;33(4):528-32
   PubMedGoogle Scholar
• Atmaca M, Yildirim H, Ozdemir H, et al. Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine. Psychol Med 2007;37(1):121-9
   PubMed Web of Science ®Google Scholar
• Hajek T, Calkin C, Blagdon R, et al. Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders. Biol Psychiatry 2013; [ Epub ahead of print]
   Google Scholar
• Bates TE, Strangward M, Keelan J, et al. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 1996;7(8):1397-400
   PubMedGoogle Scholar
• Stork C, Renshaw PF. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 2005;10(10):900-19
   PubMed Web of Science ®Google Scholar
• Warsh JJ, Andreopoulos S, Li PP. Role of intracellular calcium signaling in the pathophysiology and pharmacotherapy of bipolar disorder: current status. Clin Neurosci Res 2004;4(3–4):201-13
   Google Scholar
• Kato T, Ishiwata M, Mori K, et al. Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder. Int J Neuropsychopharmacol 2003;6(4):379-89
   PubMedGoogle Scholar
• Kazuno AA, Munakata K, Nagai T, et al. Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet 2006;2(8):e128
   Google Scholar
• McMahon FJ, Chen YS, Patel S, et al. Mitochondrial DNA sequence diversity in bipolar affective disorder. Am J Psychiatry 2000;157(7):1058-64
   PubMedGoogle Scholar
• Mannella CA. The relevance of mitochondrial membrane topology to mitochondrial function. Biochim Biophys Acta 2006;1762(2):140-7
   PubMedGoogle Scholar
• Machado-Vieira R, Pivovarova NB, Stanika RI, et al. The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder. Biol Psychiatry 2011;69(4):344-52
   PubMedGoogle Scholar
• Soeiro-de-Souza MG, Salvadore G, Moreno RA, et al. Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder. Neuropsychopharmacology 2013;38(3):468-75
   PubMedGoogle Scholar
• Moutsatsou P, Tsoporis JN, Salpeas V, et al. Peripheral blood lymphocytes from patients with bipolar disorder demonstrate apoptosis and differential regulation of advanced glycation end products and S100B. Clin Chem Lab Med 2014;52(7):999-1007
   PubMedGoogle Scholar
• Manji H, Kato T, Di Prospero NA, et al. Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci 2012;13(5):293-307
   PubMed Web of Science ®Google Scholar
• Hunsberger JG, Austin D, Chen G, Manji HK. Cellular mechanisms underlying affective resiliency: The role of glucocorticoid receptor-and mitochondrially-mediated plasticity. Brain Res 2009;1293:76-84
   PubMed Web of Science ®Google Scholar